zlacker

>>giulio+(OP)
This headline is a touch misleading as it gives the impression of being across all US households, the quote is:

>Within six months of starting a GLP-1 medication, households reduce grocery spending by an average of 5.3%. Among higher-income households, the drop is even steeper, at more than 8%. Spending at fast-food restaurants, coffee shops and other limited-service eateries falls by about 8%.

>>quitit+G7
That works out to something like $30-100 a month for most households. A bit disappointing for those hoping the savings on food would pay for the drug at the current drug prices.

>>tzs+xd
The cash-payer (no insurance) price of GLP-1's has fallen by about 70% since I started on them 18 months ago, from around $1100/mo to $350/mo, for brand-name non-compounded (Ozempic, Zepbound, etc). Many people also stretch that 1 month supply to last longer, as well (eg "click counting").

Not to say that it's cheap, but they are no longer the high-priced drugs only for the glitterati that you may be thinking.

>>jasong+Sh
n=1, I pay $300/month for 2.5mg of Zepbound (tirzepatide) for cash pay direct via http://lilly.com/, shipped to my door.

(no affiliation, I just like the drug)

>>toomuc+0C
LillyDirect is $400-450 for standard doses though. 2.5mg is just a starter and most people should be off of that dose pretty soon after they start.

FWIW tirzepatide is the more expensive of the GLP1s right now.

>>kube-s+dL
> FWIW tirzepatide is the more expensive of the GLP1s right now.

That's not surprising, it is the most effective -- for now. On the gray market, reta is even more expensive than tirz, and also more effective. I expect it will be the most expensive at retail, as well, and I hope that the net effect is to make tirz more affordable.